Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_assertion type Assertion NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_head.
- NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_assertion description "[Neutralization of RSV-CM with antibodies to interferon (IFN)-beta largely blocked TAP1/LMP2/LMP7 expression, whereas anti-interleukin-1 antibodies were without effect, and recombinant IFN-beta increased TAP1/LMP2/LMP7 expression to levels produced by RSV-CM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_provenance.
- NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_assertion evidence source_evidence_literature NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_provenance.
- NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_assertion SIO_000772 11159003 NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_provenance.
- NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_assertion wasDerivedFrom befree-20140225 NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_provenance.
- NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_assertion wasGeneratedBy ECO_0000203 NP208692.RAAzOacflOK37xChnP834sCP_uv1eo-XgOGt6N9GmBVcI130_provenance.